Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

GSK and other Olympic sponsors may face hacking attack

IT security firm claims ‘hacktivist’ network Anonymous could target websites of London 2012 partners

GlaxoSmithKline could be targeted by 'hacktivist' network Anonymous, according to reports.

IT security firm Radware claims to have found evidence the hacking network, which earlier this year took down several UK government sites, is preparing to launch a denial-of-service attack on the pharma company's website.

Carl Herberger, vice president of security solutions at Radware, told Network World US that online posts indicate Anonymous could attack GSK and telecoms firm BT, both of whom are prominent sponsors of the London 2012 Games.

While there is, as expected, no way of verifying the information, which comes from someone claiming links with Anonymous, Herberger said some previous attacks have followed a similar pattern.

The potential threat emerged just over a year Bayer's Italian website was hit by 'illegal interference' by hackers affiliated with Anonymous in June, 2011.

Meanwhile, a separate UK group called The Script Kiddies took over Pfizer's Facebook page last July, defacing it and adding links to several articles critical of the pharma company.

1st August 2012

From: Marketing

Share

Tags


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna medical communications

We believe impactful educational programmes need to demonstrate creativity in concept, strategy and execution. Our team of scientific advisors and...

Latest intelligence

Designing Human Experiences
Applying science to the creative process to improve lives...
Assured Global Delivery at The Right Temperature®
CSafe Global partners with DHL Global Forwarding to assure pharmaceutical manufacturer successful temperature sensitive delivery to South America....
The changing regulatory environment
Code of practice changes are encouraging transparency in pharma/HCP relationships...